Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Alcohol Clin Exp Res ; 36(3): 443-56, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22014285

ABSTRACT

BACKGROUND: Studies at the behavioral and synaptic level show that effects of ethanol on the central nervous system can involve the opioid signaling system. These interactions may alter the function of a common downstream target. In this study, we examined Ca(2+) channel function as a potential downstream target of interactions between ethanol and µ or κ opioid receptor signaling. METHODS: The studies were carried out in a model system, undifferentiated PC12 cells transfected with µ or κ opioid receptors. The PC12 cells express L-type Ca(2+) channels, which were activated by K(+) depolarization. Ca(2+) imaging was used to measure relative Ca(2+) flux during K(+) depolarization and the modulation of Ca(2+) flux by opioids and ethanol. RESULTS: Ethanol, µ receptor activation, and κ receptor activation all reduced the amplitude of the Ca(2+) signal produced by K(+) depolarization. Pretreatment with ethanol or combined treatment with ethanol and µ or κ receptor agonists caused a reduction in the amplitude of the Ca(2+) signal that was comparable to or smaller than that observed for the individual drugs alone, indicating an interaction by the drugs at a downstream target (or targets) that limited the modulation of Ca(2+) flux through L-type Ca(2+) channels. CONCLUSIONS: These studies provide evidence for a cellular mechanism that could play an important role in ethanol regulation of synaptic transmission and behavior through interactions with the opioid signaling.


Subject(s)
Calcium Channels, L-Type/metabolism , Calcium/metabolism , Ethanol/pharmacology , Receptors, Opioid, kappa/physiology , Receptors, Opioid, mu/physiology , Animals , Drug Interactions/physiology , Dynorphins/pharmacology , Enkephalin, Ala(2)-MePhe(4)-Gly(5)-/pharmacology , Membrane Potentials/drug effects , Membrane Potentials/physiology , Molecular Imaging/methods , PC12 Cells , Potassium/pharmacology , Rats , Receptors, Opioid, kappa/agonists , Receptors, Opioid, mu/agonists , Signal Transduction/drug effects , Signal Transduction/physiology
2.
Brain Behav Immun ; 25 Suppl 1: S106-19, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21356306

ABSTRACT

Elevated expression of neuroinflammatory factors in the central nervous system (CNS) contributes to the cognitive impairment in CNS disorders such as injury, disease and neurodegenerative disorders. However, information on the role of specific neuroimmune factors in normal and abnormal CNS function is limited. In this study, we investigated the effects of chronic exposure to the chemokine CCL2 on hippocampal synaptic function at the Schaffer collateral-CA1 synapse, a synapse that is known to play an important role in cognitive functions such as memory and learning. Synaptic function was measured in vitro using hippocampal slices obtained from transgenic mice that express elevated levels of CCL2 in the CNS through astrocyte expression and their non-transgenic littermate controls. Extracellular field potential electrophysiological recordings showed a significant reduction in the magnitude of synaptic responses in hippocampal slices from the CCL2 transgenic mice compared with slices from non-transgenic littermate controls. Two forms of short-term synaptic plasticity (post-tetanic potentiation and short-term potentiation) thought to be important cellular mechanisms of short-term memory were enhanced in hippocampal slices from CCL2 transgenic mice compared to non-transgenic hippocampal slices, whereas long-term synaptic plasticity (LTP), which is critical to long-term memory formation, was not altered. Western blot analysis of hippocampus from the CCL2 transgenic mice and non-transgenic mice showed no change in level of neuronal specific enolase, a neuronal specific protein, GFAP, an astrocyte specific protein, and several synaptic proteins compared with non-transgenic littermate controls. These results show that CCL2, which is known to be chronically produced at elevated levels within the CNS in a number of CNS disorders, can significantly alter hippocampal function and implicate a role for CCL2 in the cognitive dysfunction associated with these CNS disorders.


Subject(s)
Astrocytes/metabolism , Chemokine CCL2/metabolism , Hippocampus/physiology , Neuronal Plasticity/physiology , Neurons/metabolism , Synaptic Transmission/physiology , Animals , Blotting, Western , Chemokine CCL2/genetics , Electrophysiology , Genotype , Mice , Mice, Transgenic , Synapses/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...